Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedPhase 3

NCT01596335

Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease

The purpose of this study is to evaluate the efficacy and safety of TA-650 in comparison with a control drug Polyethylene Glycol-treated Human Immunoglobulin (V…

Japan31 participantsStarted 2012-05

Treatment: TA-650, Polyethylene Glycol-treated Human Immunoglobulin (VGIH)